Australia appears to be experience potentially transformative medication for weight issues: Retatrutide. The dual molecule – working on both GLP-1 and GIP receptors – has significant results in clinical studies, indicating substantial drops in body fat. While approval hasn't occurred with Australian regulators, many individuals battling obesity